Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer
Authors
Keywords
PAR<sub>1</sub> PAR<sub>2</sub>, Protease, GPCR, Thrombin, Breast tumor
Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 71, Issue 13, Pages 2517-2533
Publisher
Springer Nature
Online
2013-10-31
DOI
10.1007/s00018-013-1498-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transactivation of the PAR1-PAR2 Heterodimer by Thrombin Elicits β-Arrestin-mediated Endosomal Signaling
- (2013) Huilan Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure of the human κ-opioid receptor in complex with JDTic
- (2012) Huixian Wu et al. NATURE
- Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
- (2011) Eric Reiter et al. Annual Review of Pharmacology and Toxicology
- We Can Do It Together: PAR1/PAR2 Heterodimer Signaling in VSMCs
- (2011) Rafal Pawlinski et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Protease-Activated Receptor-2 Modulates Protease-Activated Receptor-1–Driven Neointimal Hyperplasia
- (2011) Leila M. Sevigny et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development
- (2010) F. Schaffner et al. BLOOD
- Protease-activated Receptor-1 (PAR1) Acts via a Novel Gα13-Dishevelled Axis to Stabilize β-Catenin Levels
- (2010) Hagit Turm et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional Selectivity and Biased Receptor Signaling
- (2010) T. Kenakin JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- PAR1 and PAR2 Couple to Overlapping and Distinct Sets of G Proteins and Linked Signaling Pathways to Differentially Regulate Cell Physiology
- (2010) K. L. McCoy et al. MOLECULAR PHARMACOLOGY
- Etk/Bmx Regulates Proteinase-Activated-Receptor1 (PAR1) in Breast Cancer Invasion: Signaling Partners, Hierarchy and Physiological Significance
- (2010) Irit Cohen et al. PLoS One
- Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
- (2010) B. Wu et al. SCIENCE
- Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
- (2010) E. Y. T. Chien et al. SCIENCE
- Dimerization in GPCR mobility and signaling
- (2009) Martin J Lohse CURRENT OPINION IN PHARMACOLOGY
- Protease-Activated Receptor (PAR) 2, but not PAR1, Signaling Promotes the Development of Mammary Adenocarcinoma in Polyoma Middle T Mice
- (2008) H. H. Versteeg et al. CANCER RESEARCH
- Slamming the DOR on chemokine receptor signaling: Heterodimerization silences ligand-occupied CXCR4 and δ-opioid receptors
- (2008) Dale Hereld et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Protease activated receptor-1, PAR1, promotes placenta trophoblast invasion and β-catenin stabilization
- (2008) Sorina Grisaru-Granovsky et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Structure of a β1-adrenergic G-protein-coupled receptor
- (2008) Tony Warne et al. NATURE
- The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist
- (2008) V.-P. Jaakola et al. SCIENCE
- A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic Receptor
- (2008) Michael A. Hanson et al. STRUCTURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now